Evidence map›Paper›PMID 25339670›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.

Ashutosh K Mangalam, Ningling Luo, David Luckey, Louisa Papke, Alyssa Hubbard, Arika Wussow, Michele Smart, Shailendra Giri, Moses Rodriguez, Chella David

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Human CommensalFrontiers in immunology · 2020
    Article
  15. Article
  16. Article
  17. Frontiers in immunology · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ashutosh K MangalamDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; Department of Neurology, Mayo Clinic, Rochester, MN 55905; and mangalam.ashutosh@mayo.edu.
Ningling LuoDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
David LuckeyDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
Louisa PapkeDepartment of Neurology, Mayo Clinic, Rochester, MN 55905; and.
Alyssa HubbardDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
Arika WussowDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
Michele SmartDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
Shailendra GiriDepartment of Neurology, Henry Ford Health System, Detroit, MI 48202.
Moses RodriguezDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; Department of Neurology, Mayo Clinic, Rochester, MN 55905; and.
Chella DavidDepartment of Immunology, Mayo Clinic, Rochester, MN 55905;
WinnMed · USMayo Clinic · USHenry Ford Health System · USMayo Clinic in Arizona · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Role of HLA Class II Genes in DemyelinationR01NS052173 · NINDS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S · 2006 to 2014
$2.5M
NCATS NIH HHS UL1 TR000135NINDS NIH HHS NS52173NINDS NIH HHS R01 NS052173
6 · The paper itself

Abstract

Multiple sclerosis is an inflammatory, demyelinating disease of the CNS of presumed autoimmune origin. Of all the genetic factors linked with multiple sclerosis, MHC class II molecules have the strongest association. Generation of HLA class II transgenic (Tg) mice has helped to elucidate the role of HLA class II genes in chronic inflammatory and demyelinating diseases. We have shown that the human HLA-DRB1*0301 gene predisposes to proteolipid protein (PLP)-induced experimental autoimmune encephalomyelitis (EAE), whereas HLA-DQβ1*0601 (DQ6) was resistant. We also showed that the DQ6 molecule protects from EAE in DRB1*0301.DQ6 double-Tg mice by producing anti-inflammatory IFN-γ. HLA-DQβ1*0302 (DQ8) Tg mice were also resistant to PLP(91-110)-induced EAE, but production of proinflammatory IL-17 exacerbated disease in DRB1*0301.DQ8 mice. To further confirm the role of IFN-γ in protection, we generated DRB1*0301.DQ8 mice lacking IFN-γ (DRB1*0301.DQ8.IFN-γ(-/-)). Immunization with PLP(91-110) peptide caused atypical EAE in DRB1*0301.DQ8.IFN-γ(-/-) mice characterized by ataxia, spasticity, and dystonia, hallmarks of brain-specific disease. Severe brain-specific inflammation and demyelination in DRB1*0301.DQ8.IFN-γ(-/-) mice with minimal spinal cord pathology further confirmed brain-specific pathology. Atypical EAE in DRB1*0301.DQ8.IFN-γ(-/-) mice was associated with increased encephalitogenicity of CD4 T cells and their ability to produce greater levels of IL-17 and GM-CSF compared with DRB1*0301.DQ8 mice. Further, areas with demyelination showed increased presence of CD68(+) inflammatory cells, suggesting an important role for monocytes/microglia in causing brain pathology. Thus, our study supports a protective role for IFN-γ in the demyelination of brain through downregulation of IL-17/GM-CSF and induction of neuroprotective factors in the brain by monocytes/microglial cells.

Indexed as

AnimalsBrainEncephalomyelitis, Autoimmune, ExperimentalGene Expression RegulationGranulocyte-Macrophage Colony-Stimulating FactorHLA-DQ AntigensHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansInterferon-gammaInterleukin-17MiceMice, KnockoutMicrogliaMonocytesMyelin Proteolipid ProteinGranulocyte-Macrophage Colony-Stimulating FactorHLA-DQ8 antigenHLA-DQ AntigensHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1*03:01 antigenHLA-DRB1 ChainsInterferon-gammaInterleukin-17Myelin Proteolipid Protein

Identifiers

PMID25339670
PMCPMC4233133
OpenAlexW1957968460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.